KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Equity Ratio: 2010-2025

Historic Equity Ratio for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to 0.40.

  • Emergent BioSolutions' Equity Ratio rose 15.89% to 0.40 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.40, marking a year-over-year increase of 15.89%. This contributed to the annual value of 0.35 for FY2024, which is 2.45% down from last year.
  • Per Emergent BioSolutions' latest filing, its Equity Ratio stood at 0.40 for Q3 2025, which was up 5.37% from 0.38 recorded in Q2 2025.
  • Emergent BioSolutions' Equity Ratio's 5-year high stood at 0.57 during Q1 2022, with a 5-year trough of 0.26 in Q2 2024.
  • Over the past 3 years, Emergent BioSolutions' median Equity Ratio value was 0.37 (recorded in 2023), while the average stood at 0.37.
  • Per our database at Business Quant, Emergent BioSolutions' Equity Ratio tumbled by 41.93% in 2024 and then surged by 48.25% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Equity Ratio (Quarterly) stood at 0.54 in 2021, then declined by 19.56% to 0.44 in 2022, then dropped by 18.74% to 0.36 in 2023, then declined by 2.45% to 0.35 in 2024, then climbed by 15.89% to 0.40 in 2025.
  • Its Equity Ratio was 0.40 in Q3 2025, compared to 0.38 in Q2 2025 and 0.39 in Q1 2025.